Related Experiment Video

Updated: Jul 8, 2026

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

Gene expression profiling of peripheral blood mononuclear cells from patients with minimal change nephrotic syndrome

Atsushi Komatsuda1, Hideki Wakui, Keiko Iwamoto

  • 1Third Department of Internal Medicine, Akita University School of Medicine, Akita, Japan.

American Journal of Nephrology
|January 26, 2008
PubMed
Abstract

Insights

Minimal change nephrotic syndrome (MCNS) involves immune dysfunction. Researchers identified specific gene expressions, CCL13 and HSPC159, in peripheral blood mononuclear cells (PBMC) during active disease phases.

Area of Science:

  • Nephrology
  • Immunology
  • Molecular Biology

Background:

  • Minimal change nephrotic syndrome (MCNS) is linked to immune cell dysfunction and potential glomerular permeability factors.
  • The exact nature of these factors in MCNS remains unclear, necessitating further investigation into underlying molecular mechanisms.

Purpose of the Study:

  • To investigate gene expression profiles in peripheral blood mononuclear cells (PBMC) of MCNS patients.
  • To identify potential biomarkers associated with the nephrotic phase of MCNS.

Main Methods:

  • Gene expression profiling using cDNA microarrays on PBMC from MCNS patients during nephrosis and remission.
  • Quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) validation of selected genes in MCNS, membranous nephropathy (MN), and healthy controls.

Main Results:

  • 171 functionally known genes were upregulated in MCNS PBMC during nephrosis, with 21 related to signal transduction and cytokine response.
  • CCL13 and HSPC159 mRNA expression was significantly higher in MCNS patients during nephrosis compared to remission, MN patients, and healthy controls.
  • These specific mRNA expression patterns were distinct in MCNS patients, unlike the variable patterns observed in MN patients.

Conclusions:

  • CCL13 and HSPC159 mRNA expressions in PBMC are specifically upregulated in MCNS patients during the nephrotic phase.
  • These findings suggest a potential role for CCL13 and HSPC159 in MCNS pathogenesis.
  • Further research is required to elucidate the direct involvement of these upregulated genes in the pathophysiological processes of MCNS.

More Related Videos

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes11:47

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes

Published on: March 4, 2022

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
DNA Microarrays02:34

DNA Microarrays

Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...